Lion Biotechnologies to Raise Approximately $23 Million in Private Financing Read more about Lion Biotechnologies to Raise Approximately $23 Million in Private Financing
Lion Biotechnologies Completes $23.3 Million Private Financing Read more about Lion Biotechnologies Completes $23.3 Million Private Financing
Lion Biotechnologies to Present at the LD MICRO Conference on December 3 Read more about Lion Biotechnologies to Present at the LD MICRO Conference on December 3
Lion Biotechnologies Appoints James Bender, Ph.D., as Vice President, Product Development and Manufacturing Read more about Lion Biotechnologies Appoints James Bender, Ph.D., as Vice President, Product Development and Manufacturing
Lion Biotechnologies to Present at the Biotech Showcase on January 15 Read more about Lion Biotechnologies to Present at the Biotech Showcase on January 15
Lion Biotechnologies’ CEO Manish Singh, Ph.D., to Chair Opening Session at Phacilitate’s Immunotherapy Forum on January 27 Read more about Lion Biotechnologies’ CEO Manish Singh, Ph.D., to Chair Opening Session at Phacilitate’s Immunotherapy Forum on January 27
Lion Biotechnologies Issues Letter to Shareholders Read more about Lion Biotechnologies Issues Letter to Shareholders
Lion Biotechnologies to Present at the 26th Annual ROTH Conference Read more about Lion Biotechnologies to Present at the 26th Annual ROTH Conference
Lion Biotechnologies to Present at the 4th Annual Cancer Immunotherapy Conference Read more about Lion Biotechnologies to Present at the 4th Annual Cancer Immunotherapy Conference
Lion Biotechnologies to Present at the BioCentury Future Leaders Conference Read more about Lion Biotechnologies to Present at the BioCentury Future Leaders Conference